fbpx

Amblyoptica Clinical Trial Criteria

Amblyopia is a neurodevelopmental disorder of vision typically manifesting as reduced visual acuity in one eye and abnormal binocular function.

Amblyopia is a neurodevelopmental disorder of vision typically manifesting as reduced visual acuity in one eye and abnormal binocular function.

Amblyopia is a neurodevelopmental disorder of vision typically manifesting as reduced visual acuity in one eye and abnormal binocular function. Current treatments for amblyopia are usually administered in childhood and include occlusion or “patching”.

This trial involves treatment using a prototype device (the Amblyoptica device) The device is worn in a manner like spectacles. The purpose of this trial is to assess if there is any improvement in visual acuity and binocular function in people with amblyopia (Lazy Eye).

Criteria

Inclusion Criteria

  • Participants should be between 8 and 50 years of age, with a history of previous, but not current, active treatment for amblyopia associated with anisometropia and/or strabismus.
  • Unilateral amblyopia best-corrected visual acuity 6/12 to 6/60 inclusive, fellow eye ≤6/7.5.
  • Anisometropia defined as a spherical equivalent difference of ≥0.50 D between the eyes, or a difference of astigmatism in any meridian ≥1.50D.
  • Strabismus defined as a manifest heterotropia at distance and/or near, or a history of strabismus surgery, or a history of strabismus resolved by hyperopic spectacle correction.

Exclusion Criteria

  • Exclusion criteria include myopia spherical equivalent greater than -6D in either eye, intraocular surgery, ocular pathology or neurological conditions.  For example, optic nerve hypoplasia.

Age Range

8 years

Gender

Both

Title of the video goes here

Lorem ipsum set emit dolor

Gallery

Related News

Bette Forgan-Smith Postdoctoral Fellowship awarded to Dr Audra Shadforth

QEI research associate, Dr Audra Shadforth has been awarded the Bette Forgan-Smith Postdoctoral Fellowship, a three-year...

 Read more

Dr Gunn joins the QEI Clinic

QEI is delighted to welcome Dr David Gunn, a Brisbane based ophthalmologist specialising in medical and surgical disease...

 Read more

Play for Purpose is back with over 7,500 prizes!

Play for Purpose is back! The Sports and Charity Raffle second game has over $500,000 worth of prizes to be won, while s...

 Read more
All blog posts

Please support our sight saving work

Your support will help us recruit the best researchers to develop better treatments, purchase the latest equipment, advance clinical trials of new treatments, improve eye health education, and support talented students to become tomorrow’s leaders in eye research.

Make a donation

COVID-19 UPDATE

Here at QEI & SBDH, the health and safety of our patients and staff is of the highest priority. That's why we are taking measures to prevent the spread of COVID-19 (Coronavirus).

We kindly ask all patients and visitors of the clinic to not enter the building if they are feeling unwell (fever, cough, sore throat or flu symptoms), have been overseas in the last two weeks or have been in contact with a known case of COVID-19.

Please contact us on 07 3239 5000 to reschedule your appointment if this applies to you. Our clinic staff are taking extra precautions through the use of face masks and extra santising measures. We would like to thank all patients and visitors for their cooperation and understanding at this time.